SeQuent Scientific Limited has entered into a Business transfer agreement with Solara Active Pharma Sciences Limited to acquire the EU-GMP API facility at Mahad (Mahad facility). The total consideration for the unit would be INR 46.4 crores on an Enterprise Valuation basis.
The acquired Mahad facility compliments the company's current manufacturing at Vizag (USFDA approved) and Tarapur (Intermediates).
Shares of SEQUENT SCIENTIFIC LTD. was last trading in BSE at Rs.61.85 as compared to the previous close of Rs. 66.75. The total number of shares traded during the day was 127332 in over 1250 trades.
The stock hit an intraday high of Rs. 69 and intraday low of 60.1. The net turnover during the day was Rs. 8133673.